发明名称 Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
摘要 Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT<SUB>1B </SUB>and 5HT<SUB>1D </SUB>antagonists.
申请公布号 NO20042140(A) 申请公布日期 2004.07.22
申请号 NO20040002140 申请日期 2004.05.25
申请人 ASTRAZENECA AB GLOBAL INTELLECTUAL PROPERTY 发明人 CHAPDELAINE MARC JEROME;DAVENPORT TIMOTHY;HAEBERLEIN MARKUS;HORCHLER CAREY;MCCAULEY JOHN;PIERSON EDWARD;SOHN DANIEL
分类号 C07D215/48;A61K31/496;A61K31/5377;A61K31/551;A61P1/00;A61P3/04;A61P5/00;A61P9/00;A61P15/00;A61P15/10;A61P21/02;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D207/14;C07D215/22;C07D215/233;C07D215/42;C07D241/04;C07D243/08;C07D265/30;C07D311/24;C07D401/04;C07D401/12;C07D401/14;C07D405/12;C07D405/14;C07D413/06;C07D413/14;C07D417/12;(IPC1-7):C07D215/42 主分类号 C07D215/48
代理机构 代理人
主权项
地址